Biotech's Complex Moment: What's Next for Europe?
Biotech just became more complicated. The hottest trend is the competitive sourcing of assets from Asia to launch newcos in the West.
At the same time, geopolitics is creating pressures against globalization and the exchange of data and talent across borders.
In its 25th year, Bio€quity Europe asks what's next for European biotech. Can it rise to the complexity of the moment? Can it match the growing competition and walk the fine line of geopolitics?
Join BioCentury, EBD Group, and Regional Host Committee Chair Flanders Investment & Trade at this destination event for biopharma decision-makers to network, partner and debate critical issues facing the biotech industry.
Faculty
Sponsors
Testimonials
“Bio€quity brings together top stakeholders in the life sciences European VC space. The event stands out by delivering quality thought leadership. For the biotech VC community, this is Europe’s flagship event.”
“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”
"Bio€quity is the leading event for the biotech industry in Europe. A masterfully organized event, it brings all actors together and creates an atmosphere and platform for true networking and business development. Complement that with a rich insights agenda that materially contributes to the discussion in the industry and the region, and you have an unmissable event."
"Bio€quity Europe is a great meeting for strategic discussions about access to capital and talent. It’s also a key networking event for investors and biopharma executives in Europe."
